Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Melanoma 5Colorectal Neoplasms 3Thyroid Neoplasms 2Ovarian Neoplasms 2Glioma 2Endometrial Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Uterine Neoplasms 1Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Stomach Neoplasms 1Rectal Neoplasms 1Prostatic Neoplasms 1Pancreatic Neoplasms 1Neurofibromatosis 1 1Neoplasm Metastasis 1Multiple Myeloma 1Lymphoma 1Lymphatic Metastasis 1Lung Neoplasms 1Hereditary Sensory and Autonomic Neuropathies 1Hematologic Neoplasms 1Fallopian Tube Neoplasms 1Esophageal Neoplasms 1Colonic Neoplasms 1Carcinoma, Renal Cell 1Carcinoma, Hepatocellular 1Breast Neoplasms 1Brain Neoplasms 1Biliary Tract Neoplasms 1

Interventions

Specimen Handling 2Magnetic Resonance Spectroscopy 2radium Ra 223 dichloride 1peposertib 1encorafenib 1cabozantinib 1binimetinib 1avelumab 1alovudine 1Surgical Procedures, Operative 1Radiosurgery 1Nivolumab 1Ipilimumab 1DNA Mismatch Repair 1CTLA-4 Antigen 1Blood Specimen Collection 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Lymphatic Metastasis × binimetinib × 30 days × Clear all
NCT04221438 2026-05-29

Testing Treatment With Encorafenib and Binimetinib Before Surgery for Melanoma With Lymph Node Involvement

Eastern Cooperative Oncology Group

Phase 2 Terminated
3 enrolled 11 charts
Dermatologic

Lymphatic Metastasis, Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡